Re-irradiation with concurrent chemotherapy in recurrent head and neck cancer: A decision analysis model based on a systematic review

Clinical Otolaryngology

Volumn 33, Issue 4, 2008, Pages 331-337

  Paleri, V ^a,b   Kelly, C G ^a  

^a NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONSENSUS; HEAD AND NECK CANCER; HUMAN; MEDICAL DECISION MAKING; MEDICAL EXPERT; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; RECURRENT CANCER; REVIEW; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

COMBINED MODALITY THERAPY; DECISION SUPPORT TECHNIQUES; HEAD AND NECK NEOPLASMS; HUMANS; MODELS, THEORETICAL; NEOPLASM RECURRENCE, LOCAL; PROBABILITY; SURVIVAL RATE;

EID: 49749121421     PISSN: 17494478     EISSN: 17494486     Source Type: Journal    
DOI: 10.1111/j.1749-4486.2008.01738.x     Document Type: Review

References (25)

1. Hong W.K., Bromer R.H., Amato D.A. et al. (1985) Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapy. Cancer 56, 1242 1245
2. Kotwall C., Sako K., Razack M.S. et al. (1987) Metastatic patterns in squamous cell cancer of the head and neck. Am. J. Surg. 154, 439 442
3. Jones A.S. (1995) The untreated patient with squamous carcinoma of the head and neck. Am. J. Clin. Oncol. 18, 363 368
4. Kao J., Garofalo M.C., Milano M.T. et al. (2003) Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review. Cancer Treat. Rev. 29, 21 30
5. Leon X., Hitt R., Constenla M. et al. (2005) A retrospective analysis of the outcome of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck refractory to a platinum-based chemotherapy. Clin Oncol (R Coll Radiol) 17, 418 424
6. Spencer S.A., Harris J., Wheeler R.H. et al. (2001) RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 51, 1299 1304
7. Dawson L.A., Myers L.L., Bradford C.R. et al. (2001) Conformal re-irradiation of recurrent and new primary head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 50, 377 385
8. De Crevoisier R., Bourhis J., Domenge C. et al. (1998) Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients. J. Clin. Oncol. 16, 3556 3562
9. Nagar Y.S., Singh S. Datta N.R. (2004) Chemo-reirradiation in persistent/recurrent head and neck cancers. Jpn. J. Clin. Oncol. 34, 61 68
10. Schaefer U., Micke O., Schueller P. et al. (2000) Recurrent head and neck cancer: retreatment of previously irradiated areas with combined chemotherapy and radiation therapy - results of a prospective study. Radiology 216, 371 376
11. Birkmeyer J.D. Welch H.G. (1997) A reader's guide to surgical decision analysis. J. Am. Coll. Surg. 184, 589 595
12. Kasperts N., Slotman B., Leemans C.R. et al. (2005) A review on re-irradiation for recurrent and second primary head and neck cancer. Oral Oncol. 41, 225 243
13. Creak A.L., Harrington K. Nutting C. (2005) Treatment of recurrent head and neck cancer: re-irradiation or chemotherapy? Clin. Oncol. (R. Coll. Radiol.) 17, 138 147
14. Salama J.K., Vokes E.E., Chmura S.J. et al. (2006) Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 64, 382 391
15. Spencer S., Wheeler R., Peters G. et al. (2003) Phase 1 trial of combined chemotherapy and reirradiation for recurrent unresectable head and neck cancer. Head Neck 25, 118 122
16. Stell P.M. (1989) Survival times in end-stage head and neck cancer. Eur. J. Surg. Oncol. 15, 407 410
17. Shaw H.J. (1985) Palliation in head and neck cancer. J. Laryngol. Otol. 99, 1131 1142
18. Wibault P., Bensmaine M.A., de Forni M. et al. (1996) Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil. J. Clin. Oncol. 14, 1192 1200
19. Ohizumi Y., Tamai Y., Imamiya S. et al. (2002) Complications following re-irradiation for head and neck cancer. Am. J. Otolaryngol. 23, 215 221
20. Detsky A.S., Naglie G., Krahn M.D. et al. (1997) Primer on medical decision analysis: Part 1 - Getting started. Med. Decis. Making 17, 123 125
21. Torrance G.W. (1986) Measurement of health state utilities for economic appraisal. J. Health Econ. 5, 1 30
22. Horsman J., Furlong W., Feeny D. et al. (2003) The Health Utilities Index (HUI(R)): concepts, measurement properties and applications. Health Qual Life Outcomes. 1, 54
23. Grootendorst P., Feeny D. Furlong W. (2000) Health Utilities Index Mark 3: evidence of construct validity for stroke and arthritis in a population health survey. Med. Care 38, 290 299
24. Jalukar V., Funk G.F., Christensen A.J. et al. (1998) Health states following head and neck cancer treatment: patient, health-care professional, and public perspectives. Head Neck 20, 600 608
25. Kelly C., Paleri V., Downs C. et al. (2007) Deterioration in quality of life and depressive symptoms during radiation therapy for head and neck cancer. Otolaryngol. Head Neck Surg. 136, 108 111